Andrew Emmett on PDUFA and the 2012 BIO International Convention

Type:

Video

Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.

November 1, 2011 Repositioning Drugs for Parkinson's Disease	September 29, 2011 Dr. Paul Offit on the Importance of Vaccines and Impediments to Breakthroughs	September 28, 2011 Bernard Siegel of the Genetics Policy Institute Discusses Stem Cell Research	September 27, 2011 Becoming a Part of the Biotech Industry
September 12, 2011 2012 World Congress on Industrial Biotechnology and Bioprocessing	September 12, 2011 Podcast: Margaret Anderson, Executive Director of FasterCures	September 9, 2011 Contagion: How Would We Respond to a Pandemic?	September 9, 2011 Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech